Elucidating the role of adipose tissue secreted factors in malignant transformation

Debrup Chakraborty1, Vanessa Benham1, Jamie J Bernard1

  • 1a Department of Pharmacology and Toxicology , Michigan State University , East Lansing , MI , USA.

Adipocyte
|November 3, 2017
PubMed

Insights

Excess body fat, specifically visceral adipose tissue, promotes skin cancer development. Fibroblast growth factor-2 (FGF2) released by this fat is a key driver in the malignant transformation of cells, linking obesity to cancer.

Area of Science:

  • Oncology
  • Metabolic Syndrome
  • Cell Biology

Background:

  • Rising incidence of obesity and obesity-linked cancers necessitates understanding the underlying mechanisms.
  • Excess adiposity's role in cancer development is not fully elucidated.
  • Previous research indicated visceral adipose tissue removal reduced UVR-initiated, high-fat diet-promoted skin cancers.

Purpose of the Study:

  • To highlight the role of fibroblast growth factor-2 (FGF2) in adiposity-associated tumorigenesis.
  • To provide additional interpretations and data supporting FGF2's function in malignant transformation.
  • To explain how excess visceral adipose tissue promotes cancer development.

Main Methods:

  • Focuses on a recently published study (Chakraborty, et al., 2017).
  • Presents new data and interpretations.
  • Examines the effects of fibroblast growth factor-2 (FGF2) released from visceral adipose tissue.

Main Results:

  • Fibroblast growth factor-2 (FGF2) released from visceral adipose tissue is a key factor in the malignant transformation of epithelial cells.
  • Demonstrates a link between FGF2, visceral adipose tissue, and cancer promotion.
  • Supports the role of FGF2 in obesity-associated tumorigenesis.

Conclusions:

  • Fibroblast growth factor-2 (FGF2) is a critical mediator linking visceral adipose tissue to cancer development.
  • Excess adiposity contributes to tumorigenesis through FGF2 signaling.
  • Further research into FGF2 pathways may reveal therapeutic targets for obesity-related cancers.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K